Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.21 +0.03 (+0.72%)
As of 03:51 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.15 billion
P/E Ratio
22.16
Consensus Rating
Strong Buy
Volume
20,009 shares
Average Volume
82,004 shares
Today's Range
$4.17
$4.22
Senseonics stock logo

2. Senseonics NYSE:SENS

$0.41 -0.02 (-3.85%)
Closing price 03:59 PM Eastern
Extended Trading
$0.41 +0.00 (+0.98%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about Senseonics

Market Capitalization
$331.58 million
P/E Ratio
-3.13
Consensus Rating
Buy
Consensus Price Target
$1.54 (+277.8% Upside)
Volume
7.05 million shares
Average Volume
8.15 million shares
Ultrapar Participacoes stock logo

3. Ultrapar Participacoes NYSE:UGP

$3.88 +0.06 (+1.44%)
Closing price 03:59 PM Eastern
Extended Trading
$3.88 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$4.32 billion
P/E Ratio
8.61
Consensus Rating
Buy
Consensus Price Target
$4.50 (+16.1% Upside)
Volume
1.19 million shares
Average Volume
1.87 million shares
Perspective Therapeutics stock logo

4. Perspective Therapeutics NYSEAMERICAN:CATX

$4.49 -0.26 (-5.56%)
Closing price 03:59 PM Eastern
Extended Trading
$4.50 +0.01 (+0.20%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$333.13 million
Consensus Rating
Buy
Consensus Price Target
$12.70 (+183.1% Upside)
Volume
1.30 million shares
Average Volume
943,559 shares
Today's Range
$4.38
$4.83
Western Copper & Gold stock logo

5. Western Copper & Gold NYSE:WRN

$2.18 -0.29 (-11.74%)
As of 03:53 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$439.61 million
P/E Ratio
-109.00
Consensus Rating
Buy
Consensus Price Target
$4.25 (+95.0% Upside)
Volume
2.54 million shares
Average Volume
493,158 shares
Foghorn Therapeutics stock logo

6. Foghorn Therapeutics NASDAQ:FHTX

$3.96 -0.36 (-8.24%)
Closing price 03:59 PM Eastern
Extended Trading
$4.00 +0.05 (+1.26%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Foghorn Therapeutics Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. More about Foghorn Therapeutics

Market Capitalization
$223.58 million
P/E Ratio
-3.32
Consensus Rating
Buy
Consensus Price Target
$11.00 (+178.1% Upside)
Volume
237,174 shares
Average Volume
130,245 shares
CuriosityStream stock logo

7. CuriosityStream NASDAQ:CURI

$4.41 -0.15 (-3.20%)
Closing price 03:59 PM Eastern
Extended Trading
$4.42 +0.00 (+0.02%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStream

Market Capitalization
$255.70 million
P/E Ratio
-49.04
Consensus Rating
Buy
Consensus Price Target
$6.33 (+43.5% Upside)
Volume
443,896 shares
Average Volume
583,421 shares
Climb Bio stock logo

8. Climb Bio NASDAQ:CLYM

$1.94 -0.01 (-0.51%)
As of 03:46 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$131.45 million
P/E Ratio
-2.77
Consensus Rating
Buy
Consensus Price Target
$9.20 (+374.2% Upside)
Volume
599,415 shares
Average Volume
413,492 shares
Marker Therapeutics stock logo

9. Marker Therapeutics NASDAQ:MRKR

$1.01 -0.02 (-1.46%)
Closing price 03:58 PM Eastern
Extended Trading
$1.04 +0.03 (+2.96%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Marker Therapeutics, Inc, a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. More about Marker Therapeutics

Market Capitalization
$13.13 million
P/E Ratio
-0.74
Consensus Rating
Buy
Consensus Price Target
$13.17 (+1,197.2% Upside)
Volume
188,159 shares
Average Volume
738,223 shares
Cardiol Therapeutics stock logo

10. Cardiol Therapeutics NASDAQ:CRDL

$1.04 0.00 (-0.29%)
Closing price 03:59 PM Eastern
Extended Trading
$1.03 0.00 (-0.19%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$90.70 million
P/E Ratio
-3.05
Consensus Rating
Buy
Consensus Price Target
$8.00 (+671.5% Upside)
Volume
584,494 shares
Average Volume
447,361 shares
Nano-X Imaging stock logo

11. Nano-X Imaging NASDAQ:NNOX

$4.00 -0.13 (-3.03%)
Closing price 03:59 PM Eastern
Extended Trading
$4.00 +0.01 (+0.25%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. More about Nano-X Imaging

Market Capitalization
$230.83 million
P/E Ratio
-4.44
Consensus Rating
Buy
Consensus Price Target
$8.50 (+112.8% Upside)
Volume
1.33 million shares
Average Volume
1.68 million shares
Innventure stock logo

12. Innventure NASDAQ:INV

$3.46 +0.42 (+13.82%)
As of 03:51 PM Eastern

Innventure Inc founds, funds and operates companies with a focus on transformative, sustainable technology solutions acquired or licensed from multinational corporations. More about Innventure

Market Capitalization
$193.86 million
Consensus Rating
Buy
Consensus Price Target
$14.00 (+304.6% Upside)
Volume
561,506 shares
Average Volume
160,468 shares
Today's Range
$2.95
$3.70
TuHURA Biosciences stock logo

13. TuHURA Biosciences NASDAQ:HURA

$2.40 +0.01 (+0.21%)
Closing price 03:59 PM Eastern
Extended Trading
$2.40 -0.01 (-0.42%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$122.90 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+426.7% Upside)
Volume
208,975 shares
Average Volume
289,646 shares
Today's Range
$2.34
$2.48
Plus Therapeutics stock logo

14. Plus Therapeutics NASDAQ:PSTV

$0.62 +0.00 (+0.31%)
Closing price 03:59 PM Eastern
Extended Trading
$0.62 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus Therapeutics

Market Capitalization
$61.14 million
P/E Ratio
-0.27
Consensus Rating
Buy
Consensus Price Target
$8.00 (+1,198.7% Upside)
Volume
4.36 million shares
Average Volume
20.75 million shares
Vizsla Silver stock logo

15. Vizsla Silver NYSEAMERICAN:VZLA

$4.51 -0.36 (-7.41%)
Closing price 03:59 PM Eastern
Extended Trading
$4.51 +0.01 (+0.13%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vizsla Silver Corp. engages in the exploration, and development of precious and base metal assets. The company explores for gold, silver, and copper deposits. More about Vizsla Silver

Market Capitalization
$1.54 billion
P/E Ratio
-112.73
Consensus Rating
Buy
Consensus Price Target
$3.25 (-27.9% Downside)
Volume
6.15 million shares
Average Volume
3.14 million shares
Quince Therapeutics stock logo

16. Quince Therapeutics NASDAQ:QNCX

$1.86 -0.08 (-3.89%)
Closing price 03:58 PM Eastern
Extended Trading
$1.84 -0.02 (-1.08%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$99.63 million
P/E Ratio
-1.70
Consensus Rating
Buy
Consensus Price Target
$8.14 (+339.0% Upside)
Volume
143,458 shares
Average Volume
247,921 shares
Talphera stock logo

17. Talphera NASDAQ:TLPH

$1.08 -0.09 (-7.33%)
Closing price 03:58 PM Eastern
Extended Trading
$1.04 -0.03 (-2.79%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. More about Talphera

Market Capitalization
$49.01 million
P/E Ratio
-2.69
Consensus Rating
Buy
Consensus Price Target
$5.00 (+365.1% Upside)
Volume
374,195 shares
Average Volume
916,977 shares
Ur Energy stock logo

18. Ur Energy NYSEAMERICAN:URG

$1.60 -0.15 (-8.51%)
Closing price 03:59 PM Eastern
Extended Trading
$1.60 0.00 (-0.06%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$587.94 million
P/E Ratio
-9.42
Consensus Rating
Buy
Consensus Price Target
$2.44 (+52.4% Upside)
Volume
16.78 million shares
Average Volume
6.40 million shares
CytomX Therapeutics stock logo

19. CytomX Therapeutics NASDAQ:CTMX

$3.20 -0.09 (-2.59%)
Closing price 03:59 PM Eastern
Extended Trading
$3.20 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX Therapeutics

Market Capitalization
$526.89 million
P/E Ratio
5.71
Consensus Rating
Buy
Consensus Price Target
$5.42 (+69.5% Upside)
Volume
975,210 shares
Average Volume
3.34 million shares
TriSalus Life Sciences stock logo

20. TriSalus Life Sciences NASDAQ:TLSI

$5.00 +0.25 (+5.16%)
Closing price 03:59 PM Eastern
Extended Trading
$5.01 +0.01 (+0.30%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$249.10 million
P/E Ratio
-4.23
Consensus Rating
Buy
Consensus Price Target
$10.90 (+118.2% Upside)
Volume
182,048 shares
Average Volume
76,577 shares
Gold Royalty stock logo

21. Gold Royalty NYSE:GROY

$3.50 -0.30 (-7.78%)
Closing price 03:59 PM Eastern
Extended Trading
$3.50 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gold Royalty Corp., a precious metals-focused royalty company, provides financing solutions to the metals and mining industry. More about Gold Royalty

Market Capitalization
$595.79 million
P/E Ratio
-26.88
Consensus Rating
Buy
Consensus Price Target
$4.61 (+31.9% Upside)
Volume
4.33 million shares
Average Volume
1.89 million shares
Denison Mine stock logo

22. Denison Mine NYSEAMERICAN:DNN

$2.92 -0.17 (-5.34%)
Closing price 03:59 PM Eastern
Extended Trading
$2.92 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$2.62 billion
P/E Ratio
-48.75
Consensus Rating
Buy
Consensus Price Target
$2.75 (-6.0% Downside)
Volume
84.81 million shares
Average Volume
80.78 million shares
Compass Therapeutics stock logo

23. Compass Therapeutics NASDAQ:CMPX

$4.26 -0.26 (-5.84%)
Closing price 03:59 PM Eastern
Extended Trading
$4.26 0.00 (-0.02%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization
$588.52 million
P/E Ratio
-9.46
Consensus Rating
Moderate Buy
Consensus Price Target
$13.10 (+207.8% Upside)
Volume
1.30 million shares
Average Volume
1.42 million shares
Aclaris Therapeutics stock logo

24. Aclaris Therapeutics NASDAQ:ACRS

$1.92 -0.14 (-6.59%)
Closing price 03:59 PM Eastern
Extended Trading
$1.90 -0.01 (-0.52%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$207.45 million
P/E Ratio
-1.40
Consensus Rating
Moderate Buy
Consensus Price Target
$8.71 (+355.1% Upside)
Volume
633,148 shares
Average Volume
977,357 shares
Rezolve AI stock logo

25. Rezolve AI NASDAQ:RZLV

$4.85 -0.19 (-3.71%)
Closing price 03:59 PM Eastern
Extended Trading
$4.86 +0.00 (+0.10%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$1.01 billion
Consensus Rating
Moderate Buy
Consensus Price Target
$9.00 (+85.5% Upside)
Volume
13.14 million shares
Average Volume
10.65 million shares
Today's Range
$4.79
$5.03